ORPHAN DRUGS FOR RARE DISEASES IN THE EUROPEAN UNION: BRIDGING THE GAP BETWEEN DRUG DEVELOPMENT AND UNMET MEDICAL NEEDS?


Por: Catala-Lopez, F, Peiro, S, Genova-Maleras, R, Garcia-Altes, A, Sanfelix-Gimeno, G, Alvarez-Martin, E, Morant-Ginestar, C and Ridao, M

Publicada: 1 nov 2011
Resumen:


Filiaciones:
:
 Ctr Super Invest Salud Publ CSISP, Valencia, Spain

:
 Ctr Super Invest Salud Publ CSISP, Valencia, Spain

Genova-Maleras, R:
 Reg Hlth Council, Primary Care Gen Directorate, Madrid, Spain

Garcia-Altes, A:
 Catalan Agcy Hlth Informat Assessment & Qual CAHI, Barcelona, Spain

:
 Ctr Super Invest Salud Publ CSISP, Valencia, Spain

Alvarez-Martin, E:
 Rey Juan Carlos Univ, Madrid, Spain

:
 Ctr Super Invest Salud Publ CSISP, Valencia, Spain

 Inst Aragones Ciencias Salud I CS, Zaragoza, Spain
ISSN: 10983015





VALUE IN HEALTH
Editorial
ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA, Reino Unido
Tipo de documento: Meeting Abstract
Volumen: 14 Número: 7
Páginas: 334-334
WOS Id: 000299107100530
imagen Bronze

FULL TEXT

imagen Published Version CC BY

MÉTRICAS